Treatment | LGG | 200060 | 200080 | H40 |
---|---|---|---|---|
Tolerance to artificial gastric conditions [Viable cell number (Log CFU/mL)] | ||||
Initial cell number | 8.55±0.01a | 8.26±0.01b | 7.79±0.01c | 8.17±0.03b |
0.3% (w/v) pepsin, pH 2.5, 3 h | 8.51±0.05a | 8.29±0.01ab | 7.91±0.00b | 7.17±0.01c |
0.3% (w/v) oxgall, 24 h | 8.58±0.03a | 7.41±0.01bc | 7.75±0.02b | 8.26±0.01a |
Adhesion rate (%) | 2.34±0.26c | 1.18±0.08d | 3.42±0.49a | 2.86±0.16b |
β-Glucuronidase (nM) | 0 | 0 | 0 | 0 |
Antibiotic resistance | Gentamycin, kanamycin, streptomycin, ciprofloxacin | Gentamycin, kanamycin, ciprofloxacin | Gentamycin, kanamycin, streptomycin, ciprofloxacin | Gentamycin, kanamycin, ciprofloxacin |